The 'Zimmerman' inquiry - the good, the not so good and what now?

Latest NewsBioPharmaPodcast

BioPharmaDispatch discusses the report of the parliamentary inquiry into approval processes for new medicines and novel medical technologies with Better Access Australia co-founder and chair Felicity McNeill.

We discuss the recommendations, the lack of any overarching objective and what the raft of proposed processes and reviews actually mean.